Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 8

1.

Irinotecan plus bolus/infusional 5-Fluorouracil and leucovorin in patients with pretreated advanced pancreatic carcinoma: a multicenter experience of the Gruppo Oncologico Italia Meridionale.

Gebbia V, Maiello E, Giuliani F, Borsellino N, Arcara C, Colucci G.

Am J Clin Oncol. 2010 Oct;33(5):461-4. doi: 10.1097/COC.0b013e3181b4e3b0.

PMID:
20142727
2.

The role of the FOLFIRINOX regimen for advanced pancreatic cancer.

Conroy T, Gavoille C, Samalin E, Ychou M, Ducreux M.

Curr Oncol Rep. 2013 Apr;15(2):182-9. doi: 10.1007/s11912-012-0290-4. Review.

PMID:
23341367
3.

Nanoliposomal irinotecan plus fluorouracil and folinic acid: a new treatment option in metastatic pancreatic cancer.

Ur Rehman SS, Lim K, Wang-Gillam A.

Expert Rev Anticancer Ther. 2016 May;16(5):485-92. doi: 10.1080/14737140.2016.1174581. Epub 2016 Apr 22. Review.

PMID:
27043737
4.

The safety and efficacy of Onivyde (irinotecan liposome injection) for the treatment of metastatic pancreatic cancer following gemcitabine-based therapy.

Passero FC Jr, Grapsa D, Syrigos KN, Saif MW.

Expert Rev Anticancer Ther. 2016 Jul;16(7):697-703. doi: 10.1080/14737140.2016.1192471. Epub 2016 Jun 3. Review.

PMID:
27219482
5.

Pancreatic cancer and FOLFIRINOX: a new era and new questions.

Marsh Rde W, Talamonti MS, Katz MH, Herman JM.

Cancer Med. 2015 Jun;4(6):853-63. doi: 10.1002/cam4.433. Epub 2015 Feb 19. Review.

6.

Liposomal Irinotecan in the Treatment of Refractory Pancreatic Cancer.

Bien H, Mackenzie GG, Choi M.

Recent Pat Anticancer Drug Discov. 2016;11(4):376-383. Review.

PMID:
27480831
7.

MM-398 (nanoliposomal irinotecan): emergence of a novel therapy for the treatment of advanced pancreatic cancer.

Carnevale J, Ko AH.

Future Oncol. 2016 Feb;12(4):453-64. doi: 10.2217/fon.15.333. Epub 2015 Dec 21. Review.

PMID:
26685802
8.

Second-line treatment in inoperable pancreatic adenocarcinoma: A systematic review and synthesis of all clinical trials.

Nagrial AM, Chin VT, Sjoquist KM, Pajic M, Horvath LG, Biankin AV, Yip D.

Crit Rev Oncol Hematol. 2015 Dec;96(3):483-97. doi: 10.1016/j.critrevonc.2015.07.007. Epub 2015 Jul 26. Review.

PMID:
26481952

Supplemental Content

Support Center